Modern anti-HIV therapy

Modern anti-HIV therapy

Bibliographic Details
Main Authors:	M Flepp, V Schiffer
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2001-04-01
Series:	Swiss Medical Weekly
Subjects:	anti-HIV therapy HAART protease inhibitor reverse transcriptase inhibitors
Online Access:	https://www.smw.ch/index.php/smw/article/view/50

Similar Items

HIVprotI: an integrated web based platform for prediction and design of HIV proteins inhibitors
by: Abid Qureshi, et al.
Published: (2018-03-01)

Glycosystems in nanotechnology: Gold glyconanoparticles as carrier for anti-HIV prodrugs
by: Fabrizio Chiodo, et al.
Published: (2014-06-01)

Recent Progress in Synthesis, POM Analyses and SAR of Coumarin-Hybrids as Potential Anti-HIV Agents—A Mini Review
by: Mustapha Suleiman, et al.
Published: (2023-10-01)

The impact of infected T lymphocyte burst rate and viral shedding rate on optimal treatment scheduling in a human immunodeficiency virus infection
by: Anuraag Bukkuri
Published: (2020-09-01)

Plant Coumarins with Anti-HIV Activity: Isolation and Mechanisms of Action
by: Ainur D. Sharapov, et al.
Published: (2023-02-01)

Comparison of Preterm Delivery Rates between HIV-infected Pregnant Women Receiving Highly Active Antiretroviral Therapy (HAART) Containing Protease Inhibitors (PIs) and HIV-infected Pregnant Women Receiving Zidovudine Monotherapy
by: Bongkot Chakornbandit, et al.
Published: (2015-09-01)

Current Treatment of HIV Infection
by: Behice KURTARAN
Published: (2015-12-01)

Role of Proviral HIV-1 DNA Genotyping for People Living with HIV (PLWH) Who Had Low-Level Viremia While Receiving Antiretroviral Therapy
by: Lv S, et al.
Published: (2023-07-01)

Prevalence of Dyslipidemia and Metabolic Abnormalities in HIV-Infected Patients
by: Amitis Ramezani, et al.
Published: (2009-04-01)

Prevalence of Dyslipidemia and Metabolic Abnormalities in HIV-Infected Patients
by: Ramezani Amitis, et al.
Published: (2009-05-01)

HIV-1 RT Inhibitors with a Novel Mechanism of Action: NNRTIs that Compete with the Nucleotide Substrate
by: Giovanni Maga, et al.
Published: (2010-03-01)

High-level resistance to non-nucleos(t)ide reverse transcriptase inhibitor based first-line antiretroviral therapy in Ghana; A 2017 study
by: Prince Kofi Parbie, et al.
Published: (2022-08-01)

The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs
by: Giovanni Barillari
Published: (2020-05-01)

Current and Novel Inhibitors of HIV Protease
by: Jan Konvalinka, et al.
Published: (2009-12-01)

Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen
by: Jean Michel Petit, et al.
Published: (2003-09-01)

Past HIV-1 Medications and the Current Status of Combined Antiretroviral Therapy Options for HIV-1 Patients
by: Matthew Weichseldorfer, et al.
Published: (2021-10-01)

Hybrid Molecules as Potential Drugs for the Treatment of HIV: Design and Applications
by: Wissal Liman, et al.
Published: (2022-08-01)

HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors
by: Greg L. Beilhartz, et al.
Published: (2010-03-01)

Bioinspired Pyrano[2,3-<i>f</i>]chromen-8-ones: Ring C-Opened Analogues of Calanolide A: Synthesis and Anti-HIV-1 Evaluation
by: Igor A. Khalymbadzha, et al.
Published: (2024-01-01)

HIV-1 Resistance to Islatravir/Tenofovir Combination Therapy in Wild-Type or NRTI-Resistant Strains of Diverse HIV-1 Subtypes
by: Maria E. Cilento, et al.
Published: (2023-09-01)

Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
by: Valeria Famiglini, et al.
Published: (2016-02-01)

Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential
by: Fernandez C, et al.
Published: (2019-07-01)

Antiretroviral treatment and time since HIV-1 diagnosis are associated with large artery stiffness in sub-Saharan African HIV-1 patients
by: Titus F. Msoka, et al.
Published: (2016-10-01)

Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide
by: Sarah M Michienzi, et al.
Published: (2021-07-01)

Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs
by: Bluma G. Brenner, et al.
Published: (2010-11-01)

Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa
by: Adetayo Emmanuel Obasa, et al.
Published: (2020-03-01)

Identification of anti-HIV and anti-Reverse Transcriptase activity from Tetracera scandens
by: Hyeok Sang Kwon, et al.
Published: (2012-03-01)

Docking study on anti-HIV-1 activity of secondary metabolites from Zingiberaceae plants
by: Muhammad Sulaiman Zubair, et al.
Published: (2020-01-01)

HIV-1 protease and reverse transcriptase inhibition by tiger milk mushroom (Lignosus rhinocerus) sclerotium extracts: In vitro and in silico studies
by: Chanin Sillapachaiyaporn, et al.
Published: (2020-07-01)

<i>Cis</i>-Allosteric Regulation of HIV-1 Reverse Transcriptase by Integrase
by: Takao Masuda, et al.
Published: (2022-12-01)

Biochemical Manifestation of HIV Lipodystrophy Syndrome
by: Kenneth Ihenetu, PhD, et al.
Published: (2012-11-01)

Pharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection
by: Hanh Thi Pham, et al.
Published: (2020-03-01)

Design of Biphenyl-Substituted Diarylpyrimidines with a Cyanomethyl Linker as HIV-1 NNRTIs via a Molecular Hybridization Strategy
by: Yuan Lei, et al.
Published: (2020-02-01)

HIV-1 Protease and Reverse Transcriptase Inhibitory Activities of <i>Curcuma aeruginosa</i> Roxb. Rhizome Extracts and the Phytochemical Profile Analysis: In Vitro and In Silico Screening
by: Chanin Sillapachaiyaporn, et al.
Published: (2021-10-01)

Targeting HIV-1 Reverse Transcriptase Using a Fragment-Based Approach
by: Mahta Mansouri, et al.
Published: (2023-03-01)

Adverse pregnancy outcomes associated with antiretroviral therapy initiated before pregnancy and during pregnancy: a retrospective study in Hubei province, China
by: Yuting Tan, et al.
Published: (2023-05-01)

REverSe TRanscrIptase chain termination (RESTRICT) for selective measurement of nucleotide analogs used in HIV care and prevention
by: Ayokunle O. Olanrewaju, et al.
Published: (2023-01-01)

Revisiting efavirenz in the era of dolutegravir: Low-dose efavirenz, a viable alternative capable of holding its own against dolutegravir-based regimens
by: Sumit Arora, et al.
Published: (2023-01-01)

Global Conformational Dynamics of HIV-1 Reverse Transcriptase Bound to Non-Nucleoside Inhibitors
by: Peter V. Coveney, et al.
Published: (2012-07-01)

Spontaneous Mutations in HIV-1 Gag, Protease, RT p66 in the First Replication Cycle and How They Appear: Insights from an In Vitro Assay on Mutation Rates and Types
by: Joshua Yi Yeo, et al.
Published: (2020-12-01)